Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
256-270 of 582
Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
NeuroFrontiersReducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
Kelly G. Gwathmey, MD
Diagnosing Muscle Disorders: When to Use Biopsy
NeuroFrontiersDiagnosing Muscle Disorders: When to Use Biopsy
Aziz Shaibani, MD, FACP
ATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
NeuroFrontiersATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
Morie Gertz, MD, MACP
Navigating Treatment Choices for DMD: Key Factors to Consider
NeuroFrontiersNavigating Treatment Choices for DMD: Key Factors to Consider
Nancy Kuntz, MD
MRI-Driven Insights into the Pathology of Pediatric MS
NeuroFrontiersMRI-Driven Insights into the Pathology of Pediatric MS
Giulia Fadda, MD
MS Misdiagnosis: Understanding the Frequency and Consequences
NeuroFrontiersMS Misdiagnosis: Understanding the Frequency and Consequences
Andrew J. Solomon, MD
- advertisement
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
Clinician's RoundtableHow CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
Jennifer Caudle, DO, FACOFP
A. Mark Fendrick, MD
The SOPRANINO Study: Ensuring MS Treatment Safety for Breastfeeding Mothers
NeuroFrontiersThe SOPRANINO Study: Ensuring MS Treatment Safety for Breastfeeding Mothers
Riley Bove, MD, MMSc
Arman Eshaghi, MD, PhD
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Project Oncology®Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Munir Ghesani, MD
An Overview of the Fundamentals of PET-CT Imaging
Project Oncology®An Overview of the Fundamentals of PET-CT Imaging
- advertisement
Current Updates in Brain Imaging and Neurodegenerative Diseases
Project Oncology®Current Updates in Brain Imaging and Neurodegenerative Diseases
Phillip H. Kuo, MD, PhD
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Project Oncology®Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Geoffrey B. Johnson, M.D., Ph.D.
A Look at the Utility of PSMA PET Scans in Prostate Cancer
Project Oncology®A Look at the Utility of PSMA PET Scans in Prostate Cancer
Jennifer Caudle, DO, FACOFP
Geoffrey B. Johnson, M.D., Ph.D.
